Analog Devices stock dips into MLK break as Wall Street turns more bullish — what to watch next
18 January 2026
2 mins read

Analog Devices stock dips into MLK break as Wall Street turns more bullish — what to watch next

New York, Jan 17, 2026, 17:51 EST — Market closed.

  • Shares of Analog Devices slipped 0.6% by Friday’s close, despite hitting a new 52-week peak earlier in the session.
  • This week saw a series of broker notes pushing price targets higher, highlighting stronger signals from chip distributors.
  • A filing revealed that director Ray Stata sold shares through a pre-established trading plan.

Analog Devices shares slipped 0.6% to end Friday at $300.25, retreating from an earlier peak of $309.26, a 52-week high. Trading volume reached roughly 4.3 million shares.

The intraday reversal is significant since ADI is seen as a bellwether for the “analog” chip cycle — the slower, industrial-focused segment of semiconductors that usually lags the headline AI stocks. When it’s near the peak of its range, even small shifts can shake it up.

U.S. markets will be closed Monday in observance of Martin Luther King Jr. Day, reopening Tuesday. Investors are left holding a backlog of fresh research notes, but there’s scant new company news to digest. 1

Wells Fargo bumped up Analog Devices to “Overweight” from “Equal Weight” and lifted its price target to $340 from $265, according to a note shared by TheFly. In broker terms, overweight means the stock is expected to outperform the market or its sector. 2

Morgan Stanley’s Joseph Moore raised his price target to $314 from $293 and maintained an Overweight rating. He cited reports from distributors highlighting price increases, inventory accumulation, and extended lead times—the delay between ordering and delivery—as evidence of “a clearer path to a recovery acceleration.” 3

Stifel lifted its price target to $330 from $290 and reaffirmed its Buy rating in a wider outlook on analog and connectivity chipmakers. The firm noted demand appears to be bouncing back, driven by steady AI infrastructure and a shift toward processing at the “edge”—closer to devices instead of remote data centers. 4

Investors are weighing whether the surge in orders reflects real restocking—clients replenishing depleted inventories—or merely a short-lived bottleneck in the supply chain.

A regulatory filing revealed that ADI director Ray Stata sold 6,250 shares on Jan. 13 and Jan. 14, with weighted average prices between roughly $294 and $302 each. These sales were executed under a Rule 10b5-1 plan set up in January 2025, a prearranged strategy designed to ease concerns over insider trading. 5

The company’s most recent detailed update was in late November, revealing results and projecting first-quarter fiscal 2026 revenue around $3.1 billion, with a margin of plus or minus $100 million. Adjusted earnings were forecast at $2.29 per share, give or take 10 cents. 6

But the picture isn’t one-sided. When distributors mention rising inventories, it might signal a shift — or it could mean parts are stacking up once more if end-demand fails to pick up, particularly in industrial sectors known for quick downturns.

Trading picks up Tuesday, and all eyes will be on whether ADI can maintain the $300 level. Investors will also be eager to see if other companies boost their earnings estimates, not just price targets. The big event ahead remains quarterly earnings, with calendars pointing to around Feb. 18, although ADI hasn’t officially announced a date. 7

Stock Market Today

AstraZeneca stock price: What could move AZN next week as earnings loom

AstraZeneca stock price: What could move AZN next week as earnings loom

7 February 2026
AstraZeneca shares rose Friday, closing at $193.03 in New York, up 3.1%, and 14,104p in London, up 0.9%. The company reports full-year and Q4 2025 results Tuesday, with investors focused on 2026 guidance. The FDA this week issued a complete response letter for a subcutaneous Saphnelo filing, while granting Priority Review to Datroway for breast cancer. AstraZeneca recently shifted its primary U.S. listing to the NYSE.
Toyota stock price rises on CEO shake-up and higher profit outlook as buyout deadline nears

Toyota stock price rises on CEO shake-up and higher profit outlook as buyout deadline nears

7 February 2026
Toyota shares rose 2% to 3,780 yen Friday after the company raised its full-year profit forecast and announced CFO Kenta Kon will replace CEO Koji Sato on April 1. Third-quarter net revenues climbed 6.8% to 38.087 trillion yen, but North America posted a 5.6 billion yen operating loss. Toyota’s U.S. ADRs closed up 2.9%. The tender offer for Toyota Industries shares closes Feb. 12.
Texas Instruments stock climbs as Stifel lifts target; what investors watch before Jan. 27 call
Previous Story

Texas Instruments stock climbs as Stifel lifts target; what investors watch before Jan. 27 call

ARM stock price: Arm Holdings ends higher ahead of long weekend, eyes on chip rally and Feb. 4 earnings
Next Story

ARM stock price: Arm Holdings ends higher ahead of long weekend, eyes on chip rally and Feb. 4 earnings

Go toTop